A retrospective cohort study of the time between prior antibiotics and checkpoint inhibitors and association with survival in melanoma patients

J Am Acad Dermatol. 2024 Nov 15:S0190-9622(24)03186-4. doi: 10.1016/j.jaad.2024.10.083. Online ahead of print.
No abstract available

Keywords: ICI; antibiotic; cancer; dysbiosis; gut microbiome; immune checkpoint inhibitor; immunooncology; immunotherapy; malignancy; melanoma; microbiome; microbiota; mortality; outcome; response; survival.